SS
ACET icon

SBI Securities’s Adicet Bio ACET Stock Holding History

SBI Securities’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207 Buy
24
+5
+26% +$39 ﹤0.01% 3313
2026
Q1 		$129 Hold
19
– – ﹤0.01% 3348
2025
Q4 		$160 Sell
19
-33
-63% -$365 ﹤0.01% 3281
2025
Q3 		$670 Buy
52
+1
+2% +$12 ﹤0.01% 2857
2025
Q2 		$501 Buy
51
+3
+6% +$32 ﹤0.01% 2965
2025
Q1 		$577 Buy
48
+37
+336% +$529 ﹤0.01% 2812
2024
Q4 		$165 Buy
+11
New +$208 ﹤0.01% 3305

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

SBI Securities's ACET Position: Q2 2026 in Review

SBI Securities increased its Adicet Bio (ACET) stake by 26% in Q2 2026, buying an estimated $39 and bringing the position to 24 shares worth $207. The position accounts for ﹤0.01% of the portfolio, ranked #3313.

SBI Securities first reported a position in ACET in Q4 2024 and has held it in 7 quarters since. The position peaked at $670 in Q3 2025. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • SBI Securities held 24 shares of Adicet Bio worth $207 as of Q2 2026.
  • SBI Securities bought 5 Adicet Bio shares in Q2 2026, an estimated $39.
  • Adicet Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3313 holding.
  • SBI Securities first reported a position in Adicet Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Adicet Bio position peaked at $670 in Q3 2025.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.